Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8338746rdf:typepubmed:Citationlld:pubmed
pubmed-article:8338746lifeskim:mentionsumls-concept:C1123023lld:lifeskim
pubmed-article:8338746lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:8338746lifeskim:mentionsumls-concept:C0038170lld:lifeskim
pubmed-article:8338746lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:8338746pubmed:issue6lld:pubmed
pubmed-article:8338746pubmed:dateCreated1993-8-31lld:pubmed
pubmed-article:8338746pubmed:abstractTextAlthough the deleterious effect of Staphylococcus aureus on atopic eczema is well recognized, the mechanism of this effect may be more complex than pyogenic infection alone. We have shown that the majority of S. aureus cultures isolated from atopic eczema produced exotoxins with superantigenic properties, although this was no more frequent than in a control group, and was not restricted to one particular superantigen. However, the widespread nature of staphylococcal infections in atopic eczema indicates that sufficient superantigen may be released to cause T-lymphocyte activation, cytokine release, and mast cell degranulation. These mechanisms could, in part, explain the exacerbations of atopic eczema associated with S. aureus infection.lld:pubmed
pubmed-article:8338746pubmed:languageenglld:pubmed
pubmed-article:8338746pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8338746pubmed:citationSubsetIMlld:pubmed
pubmed-article:8338746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8338746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8338746pubmed:statusMEDLINElld:pubmed
pubmed-article:8338746pubmed:monthJunlld:pubmed
pubmed-article:8338746pubmed:issn0007-0963lld:pubmed
pubmed-article:8338746pubmed:authorpubmed-author:NobleW CWClld:pubmed
pubmed-article:8338746pubmed:authorpubmed-author:CampR DRDlld:pubmed
pubmed-article:8338746pubmed:authorpubmed-author:McFaddenJ PJPlld:pubmed
pubmed-article:8338746pubmed:issnTypePrintlld:pubmed
pubmed-article:8338746pubmed:volume128lld:pubmed
pubmed-article:8338746pubmed:ownerNLMlld:pubmed
pubmed-article:8338746pubmed:authorsCompleteYlld:pubmed
pubmed-article:8338746pubmed:pagination631-2lld:pubmed
pubmed-article:8338746pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8338746pubmed:meshHeadingpubmed-meshheading:8338746-...lld:pubmed
pubmed-article:8338746pubmed:meshHeadingpubmed-meshheading:8338746-...lld:pubmed
pubmed-article:8338746pubmed:meshHeadingpubmed-meshheading:8338746-...lld:pubmed
pubmed-article:8338746pubmed:meshHeadingpubmed-meshheading:8338746-...lld:pubmed
pubmed-article:8338746pubmed:meshHeadingpubmed-meshheading:8338746-...lld:pubmed
pubmed-article:8338746pubmed:meshHeadingpubmed-meshheading:8338746-...lld:pubmed
pubmed-article:8338746pubmed:year1993lld:pubmed
pubmed-article:8338746pubmed:articleTitleSuperantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin.lld:pubmed
pubmed-article:8338746pubmed:affiliationSt John's Institute of Dermatology, St Thomas' Hospital, London, U.K.lld:pubmed
pubmed-article:8338746pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8338746lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8338746lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8338746lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8338746lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8338746lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8338746lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8338746lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8338746lld:pubmed